Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• The human kinome comprises Ror1, a poorly understood orphan receptor.
• Ror1's role in cancer pathogenesis remains largely uncharacterized.

Purpose of the Study:

• To investigate the contribution of Ror1 to cancer progression.
• To elucidate the mechanisms underlying Ror1 function in cancer cell lines.

Main Methods:

• Screening of 43 cancer cell lines for Ror1 expression and tyrosine phosphorylation.
• RNA interference (RNAi)-mediated Ror1 suppression to assess growth responses.
• Biochemical assays to determine Ror1's catalytic activity and phosphorylation status.
• In vitro and in vivo assays to evaluate the impact of Ror1 silencing on proliferation and tumorigenesis.

Main Results:

• Ror1 expression was detected in approximately 75% of tested cancer cell lines.
• High Ror1 tyrosine phosphorylation and growth inhibition upon suppression were observed in gastric and non-small cell lung carcinoma cells.
• Ror1 was identified as a pseudokinase lacking catalytic activity.
• Ror1 phosphorylation was dependent on Met oncogene amplification and activation, suggesting Met-dependent transphosphorylation.
• Ror1 silencing significantly impaired proliferation in vitro and inhibited tumorigenesis in vivo.

Conclusions:

• Ror1 plays a critical role in malignant phenotypes, particularly in cancers driven by the Met oncogene.
• Met-dependent phosphorylation of the pseudokinase Ror1 is crucial for cancer cell proliferation and tumor growth.
• Targeting Ror1 may represent a therapeutic strategy for Met-driven cancers.